CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CGON CG Oncology Inc.

Pre-Mkt 04-07 07:30:19 EDT

67.55

+0.07

+0.10%

盘前67.77

+0.22+0.33%

07:05 EDT

High68.90	Low66.90	Vol1.14M
Open67.54	D1 Closing67.48	Amplitude2.96%
Mkt Cap5.70B	Tradable Cap4.58B	Total Shares84.44M
T/O77.09M	T/O Rate1.68%	Tradable Shares67.76M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":67.55,"timestamp":1775505600000,"preClose":67.48,"halted":0,"volume":1141585,"hourTrading":{"tag":"盘前","latestPrice":67.77,"preClose":67.55,"latestTime":"07:05 EDT","volume":103,"amount":6970.72997,"timestamp":1775559929124,"change":0.22,"changeRate":0.003257,"amplitude":0.02413},"delay":0,"changeRate":0.001037344398340148,"floatShares":67764900,"shares":84435200,"eps":-2.082636,"marketStatus":"Pre-Mkt","change":0.07,"latestTime":"04-07 07:30:19 EDT","open":67.54,"high":68.9,"low":66.9,"amount":77086680.12584999,"amplitude":0.029638,"askPrice":77.07,"askSize":100,"bidPrice":57.38,"bidSize":58,"shortable":3,"etf":0,"ttmEps":-2.082636,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775568600000},"marketStatusCode":1,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":67.55,"preHourTrading":{"tag":"盘前","latestPrice":67.77,"preClose":67.55,"latestTime":"07:05 EDT","volume":103,"amount":6970.72997,"timestamp":1775559929124,"change":0.22,"changeRate":0.003257,"amplitude":0.02413},"postHourTrading":{"tag":"盘后","latestPrice":67.15,"preClose":67.55,"latestTime":"18:05 EDT","volume":26818,"amount":1811406.35,"timestamp":1775513101773,"change":-0.4,"changeRate":-0.005922,"amplitude":0.006662},"volumeRatio":0.9158398248504727,"impliedVol":0.8833,"impliedVolPercentile":0.9518},"requestUrl":"/m/hq/s/CGON/tweets","defaultTab":"tweets","newsList":[{"id":"2625934133","title":"CG Oncology Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2625934133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625934133?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:41","pubTimestamp":1775558460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 07, 2026 06:41 ET (10:41 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625349339","title":"BUZZ-CG Oncology rises after brokerage lifts PT ahead of pivotal bladder cancer data","url":"https://stock-news.laohu8.com/highlight/detail?id=2625349339","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625349339?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:39","pubTimestamp":1775558368,"startTime":"0","endTime":"0","summary":"BUZZ-CG Oncology rises after brokerage lifts PT ahead of pivotal bladder cancer data** Shares of biotech firm CG Oncology CGON.O rise 1% to $67.57 premarket** Brokerage HC Wainwright raises price target on CGON to $100 from $80; reiterates \"Buy\"** Brokerage says CGON’s lead therapy, cretostimogene, is being tested to reduce tumor recurrence in an early-stage form of bladder cancer that frequently returns after surgery** Says recurrence rather than disease worsening is the main unmet need in this patient group, and that durable control would reduce repeat surgeries** Brokerage adds late-stage trial needs to show sustained benefit beyond early timepoints to beat historical chemotherapy outcomes** As of last close, stock up ~12% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4N40Q0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625318699","title":"CG Oncology price target raised to $100 from $80 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2625318699","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625318699?lang=en_us&edition=fundamental","pubTime":"2026-04-07 17:55","pubTimestamp":1775555757,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andres Maldonado raised the firm’s price target on CG Oncology (CGON) to $100 from $80 and keeps a Buy rating on the shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-100-from-80-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-100-from-80-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625593946","title":"CG Oncology, Inc. : H.c. Wainwright Raises Target Price to $100 From $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2625593946","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625593946?lang=en_us&edition=fundamental","pubTime":"2026-04-07 17:51","pubTimestamp":1775555503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nAZN4SPFUB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625933307","title":"U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2625933307","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625933307?lang=en_us&edition=fundamental","pubTime":"2026-04-07 16:04","pubTimestamp":1775549040,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO April 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Centerspac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4N40Q0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","FSLY","JNJ","AMZU","AMZY","BAC","AMZW","AX","CSX","AU","AZYY","H","CSR","FUBO","AMZZ","AJG","USAW.SI","KEY","KKR","ARCB","DOCN","HBAN","BOW","AXPG","EQIX","DLR","JBHT","AMZP","BKNG","THG","HIPO","AKAM","FBK","ICE","AXP","BX","LXU","BWIN","CME","XPO","GSHD","AMZD","BOKF","LNG","AMP","KNX","FITB","CFG","CF","AMZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625017266","title":"CG Oncology, Inc. (CGON) Gets a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2625017266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625017266?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:37","pubTimestamp":1775507846,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on CG Oncology, Inc., with a price target of $85.00. Roy covers th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3QW5Z07.USD","BK4135","IE00B64PRP62.GBP","IE00BGHQF748.EUR","CG","BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625263806","title":"A Look At CG Oncology (CGON) Valuation As It Upsizes Its Planned US$550 Million Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2625263806","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625263806?lang=en_us&edition=fundamental","pubTime":"2026-04-06 06:18","pubTimestamp":1775427535,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has moved into focus after amending its planned stock offering to US$550 million from US$250 million, a sizeable raise that ties directly to ongoing clinical development and anticipated topline trial disclosures.\nSee our latest analysis for CG Oncology.\nThe latest stock offering news comes on top of strong share price momentum, with a 30 day share price return of 9.05%, a 90 day share price return of 68.53%, and a 1 year total shareholder return of about 3x. This suggests...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/a-look-at-cg-oncology-cgon-valuation-as-it-upsizes-its-plann","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/a-look-at-cg-oncology-cgon-valuation-as-it-upsizes-its-plann","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IE00BGHQF748.EUR","CGON","CG","BK4135","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622730384","title":"LifeSci Capital Sticks to Its Buy Rating for CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622730384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622730384?lang=en_us&edition=fundamental","pubTime":"2026-03-28 22:38","pubTimestamp":1774708687,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on CG Oncology, Inc., with a price target of $108.00. Accordin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622698308","title":"UBS Adjusts Price Target on CG Oncology to $90 From $60, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2622698308","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622698308?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:27","pubTimestamp":1774535249,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has an average rating of buy and mean price target of $83.29, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622078968","title":"Cretostimogene’s PIVOT‑6 Upside: Anticipated Superiority in Recurrence‑Free Survival Supports Buy on CG Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078968","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078968?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:35","pubTimestamp":1774438521,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Brian Cheng has reiterated their bullish stance on CGON stock, giving a Buy rating yesterday. Brian Cheng has given his Buy rat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cretostimogenes-pivot‑6-upside-anticipated-superiority-in-recurrence‑free-survival-supports-buy-on-cg-oncology-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cretostimogenes-pivot‑6-upside-anticipated-superiority-in-recurrence‑free-survival-supports-buy-on-cg-oncology-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089284900.SGD","LU0006306889.USD","LU1668664300.SGD","LU1244550577.SGD","LU1791710582.SGD","LU1720051108.HKD","LU0106261372.USD","BK4581","IE00B3QW5Z07.USD","BK4127","CG","LU2133065610.SGD","LU1244550221.USD","LU1791710400.SGD","CGON","LU1548497426.USD","LU2111349929.HKD","LU1732799900.SGD","LU0267386448.USD","LU0158827781.USD","LU1162221912.USD","LU1989772923.USD","LU0528227936.USD","LU2028103732.USD","LU2271345857.HKD","LU2023251221.USD","LU0320765646.SGD","LU0234570918.USD","LU0795875086.SGD","IE00BZ1G4Q59.USD","LU0882574139.USD","LU2089283258.USD","LU1074936037.SGD","LU1720051017.SGD","LU1989772840.SGD","LU0106831901.USD","LU0557290698.USD","LU0795875169.SGD","IE00BKVL7J92.USD","BK4135","LU0225283273.USD","BK4504","BK4585","LU2347655156.SGD","LU0158827948.USD","LU0314104364.USD","LU1363072403.SGD","LU1732800096.USD","LU0098860793.USD","LU1244550494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620241013","title":"Bank of America Securities Remains a Buy on CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620241013","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620241013?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:56","pubTimestamp":1773917791,"startTime":"0","endTime":"0","summary":"In a report released today, Alec Stranahan from Bank of America Securities reiterated a Buy rating on CG Oncology, Inc., with a price target of $72...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0477156953.USD","BK4559","LU0320765489.SGD","LU1280957306.USD","LU0256863811.USD","LU0683600562.USD","IE00BFXG1179.USD","LU0170899867.USD","LU0417517546.SGD","LU0648000940.SGD","LU0130102774.USD","LU1267930227.SGD","LU1069347547.HKD","LU0208291251.USD","LU0203347892.USD","LU1201861165.SGD","LU0211331839.USD","BK4581","LU0130517989.USD","BK4504","IE0002270589.USD","LU0310800965.SGD","IE00BKVL7J92.USD","CG","LU0321505439.SGD","LU1162221912.USD","LU1883839398.USD","LU0130103400.USD","LU0477156797.USD","LU1894683348.USD","IE00B7SZLL34.SGD","LU0130518102.USD","BAC","LU0234570918.USD","LU0640476718.USD","IE0034235188.USD","LU0787776722.HKD","LU0070302665.USD","LU2129689431.USD","LU1506573853.SGD","LU0128525689.USD","LU1201861249.SGD","BK4588","LU0980610538.SGD","IE00B19Z3581.USD","IE00BGHQF748.EUR","LU1366192091.USD","LU1496350171.SGD","LU1035773651.USD","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620640823","title":"CG Oncology Director James Mulay Disposes of USD 125,412 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620640823","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620640823?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:15","pubTimestamp":1773778542,"startTime":"0","endTime":"0","summary":"James Mulay, a director of CG Oncology, reported a disposal of 1,964 common shares at USD 63.5 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLLJbqz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CG Oncology Director James Mulay Disposes of USD 125,412 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619148606","title":"How Investors May Respond To CG Oncology (CGON) Expanding ATM Offering To Advance Cretostimogene BLA Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2619148606","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619148606?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:16","pubTimestamp":1773613002,"startTime":"0","endTime":"0","summary":"In recent days, CG Oncology drew attention as multiple research firms updated their views on the company, while it expanded its at-the-market stock offering to up to US$550 million to support progress toward a Biologics License Application for its bladder cancer therapy candidate, cretostimogene.\nAnalysts pointed to recent clinical and market validation in intermediate-risk non-muscle invasive bladder cancer and CG Oncology’s advancing PIVOT-006 trial as important factors shaping how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/how-investors-may-respond-to-cg-oncology-cgon-expanding-atm","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/how-investors-may-respond-to-cg-oncology-cgon-expanding-atm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK4135","CGON","BK4211","BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","CG","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619793117","title":"CG Oncology price target raised to $72 from $65 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2619793117","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619793117?lang=en_us&edition=fundamental","pubTime":"2026-03-14 03:35","pubTimestamp":1773430527,"startTime":"0","endTime":"0","summary":"BofA analyst Alec Stranahan raised the firm’s price target on CG Oncology (CGON) to $72 from $65 and keeps a Buy rating on the shares. The firm vie...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-72-from-65-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-72-from-65-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616353810","title":"Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH), MAIA Biotechnology, Inc. (MAIA) and CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353810","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616353810?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:10","pubTimestamp":1772460635,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals (AUPH – Research Report), MAIA Biotechnol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aurinia-pharmaceuticals-auph-maia-biotechnology-inc-maia-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aurinia-pharmaceuticals-auph-maia-biotechnology-inc-maia-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XLV","IE00B64PRP62.GBP","LU0128526141.USD","IE00BGHQF748.EUR","MAIA","LABU","HCSG","BK4585","BK4137","AUPH","LU0029874061.USD","BK4135","IE00B3QW5Z07.USD","XBI","BK4581","CGON","CG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616532883","title":"CG Oncology (CGON) Valuation Check As Bladder Cancer Trial Timelines Accelerate And Cash Runway Extends To 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532883","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616532883?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:21","pubTimestamp":1772457660,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has drawn fresh attention after updating timelines for topline data from key Phase 2 and Phase 3 bladder cancer trials, while also highlighting a cash runway that management expects will extend into 2029.\nSee our latest analysis for CG Oncology.\nThe recent update on expedited trial timelines and a cash runway into 2029 comes after a strong run in the shares, with the latest close at $58.8, a 90 day share price return of 42.13% and a 1 year total shareholder return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-valuation-check-as-bladder-cancer-trial-tim","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-valuation-check-as-bladder-cancer-trial-tim","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4135","IE00B64PRP62.GBP","DCF","BK4139","CG","AAQC","IE00B3QW5Z07.USD","CGON","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614346864","title":"CG Oncology: Advancing Creto Toward 2026 BLA with Pivotal PIVOT‑006 Catalyst and Expanding NMIBC Peak Sales Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2614346864","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614346864?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:45","pubTimestamp":1772221523,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on CGON stock, giving a Buy rating today. Tyler Van Buren has given his Buy ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cg-oncology-advancing-creto-toward-2026-bla-with-pivotal-pivot‑006-catalyst-and-expanding-nmibc-peak-sales-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cg-oncology-advancing-creto-toward-2026-bla-with-pivotal-pivot‑006-catalyst-and-expanding-nmibc-peak-sales-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SKIS","CG","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614943861","title":"CG Oncology Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2614943861","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614943861?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:20","pubTimestamp":1772220000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2026 14:20 ET (19:20 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614685976","title":"Earnings Flash (CGON) CG Oncology Posts 2025 Total Revenue $4M, vs. FactSet Est of $2.8M","url":"https://stock-news.laohu8.com/highlight/detail?id=2614685976","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614685976?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:38","pubTimestamp":1772199493,"startTime":"0","endTime":"0","summary":"Earnings Flash (CGON) CG Oncology Posts 2025 Total Revenue $4M, vs. FactSet Est of $2.8M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","TSS","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614185986","title":"CG Oncology Q4 EPS $(0.51) Beats $(0.59) Estimate, Sales $2.322M Beat $1.641M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2614185986","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614185986?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:33","pubTimestamp":1772199193,"startTime":"0","endTime":"0","summary":"CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.59) by 13.56 percent. This is a 10.87 percent decrease over losses of $(0.46) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50925637/cg-oncology-q4-eps-0-51-beats-0-59-estimate-sales-2-322m-beat-1-641m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://cgoncology.com;ir.cgoncology.com","stockEarnings":[{"period":"1week","weight":0.0561},{"period":"1month","weight":0.0916},{"period":"3month","weight":0.6733},{"period":"6month","weight":0.6593},{"period":"1year","weight":2.9273},{"period":"ytd","weight":0.6269}],"compareEarnings":[{"period":"1week","weight":0.0427},{"period":"1month","weight":-0.02},{"period":"3month","weight":-0.0475},{"period":"6month","weight":-0.0211},{"period":"1year","weight":0.3041},{"period":"ytd","weight":-0.0337}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"CG Oncology Inc.","nameEN":"CG Oncology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CG Oncology Inc.(CGON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CG Oncology Inc.,CGON,CG Oncology Inc.股票,CG Oncology Inc.股票老虎,CG Oncology Inc.股票老虎国际,CG Oncology Inc.行情,CG Oncology Inc.股票行情,CG Oncology Inc.股价,CG Oncology Inc.股市,CG Oncology Inc.股票价格,CG Oncology Inc.股票交易,CG Oncology Inc.股票购买,CG Oncology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CG Oncology Inc.(CGON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}